Published in Mediators Inflamm on July 01, 2015
Oxidized Low-Density Lipoprotein Predicts the Development of Renal Dysfunction in Atrial Fibrillation. Cardiorenal Med (2016) 0.75
Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle). Circ Arrhythm Electrophysiol (2017) 0.75
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation (2001) 5.49
Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor". J Am Coll Cardiol (2009) 2.27
The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens (2010) 1.86
C-Reactive protein in lone atrial fibrillation. Am J Cardiol (2006) 1.68
Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm (2012) 1.53
Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol (2002) 1.41
Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm (2009) 1.33
High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens (2003) 1.27
Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol (2011) 1.04
Biomarkers in atrial fibrillation: an overview. Int J Clin Pract (2013) 0.99
Lone atrial fibrillation - an overview. Int J Clin Pract (2013) 0.98
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study. Circ Arrhythm Electrophysiol (2012) 0.96
The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation. Int J Cardiol (2008) 0.92
Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects. Am J Hypertens (2009) 0.89
Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO. Front Physiol (2012) 0.87
Latent arterial hypertension in apparently lone atrial fibrillation. J Interv Card Electrophysiol (2005) 0.85
Multiple biomarkers and atrial fibrillation in the general population. PLoS One (2014) 0.84
Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode. Am J Cardiol (1995) 0.84
The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation. Europace (2012) 0.83
Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL. Int J Mol Med (2011) 0.83
Impaired endothelial function in lone atrial fibrillation. Vojnosanit Pregl (2013) 0.79